SENTIA: an intensive medicines monitoring programme for proactive safety surveillance of neuroleptic treatment in children and adolescents

被引：0
|
作者：
Palanca Maresca, Inmaculada [1 ]
Ruiz-Antoran, Belen [2 ]
Olza-Fernandez, Ibone [1 ]
Siles, Ana [3 ]
Villagra, Sandra [3 ]
Fernandez Rivas, Aranzazu [4 ]
Garcia Vega, Juan Manuel [1 ]
Centeno, Gustavo [2 ]
Roman, Enriqueta [5 ]
Avendano-Sola, Cristina [2 ]
机构：
[1] Univ Puerta de Hierro, Majadahonda Hosp, Child & Adolescent Psychiat Unit, Madrid, Spain
[2] Univ Puerta de Hierro, Majadahonda Hosp, Dept Clin Pharmacol, Madrid, Spain
[3] Univ Puerta de Hierro, Majadahonda Hosp, Paediat Cardiol Unit, Madrid, Spain
[4] Basurto Hosp, Child & Adolescent Psychiat Unit, Bilbao, Spain
[5] Univ Puerta de Hierro, Majadahonda Hosp, Paediat Serv, Madrid, Spain
来源：
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | 2013年 / 22卷
关键词：
Antipsychotic; adverse effects; pharmacovigilance registry; paediatric populations;
D O I：
暂无
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
PS-046
引用
收藏
页码：S230 / S231
页数：2
相关论文
共 50 条
  • [21] Intensive safety monitoring program of antineoplastic medicines: A pilot study in a Portuguese oncology hospital
    Mendes, Diogo
    Rigueiro, Graca
    Silva, Rui S.
    Penedones, Ana
    Alves, Carlos
    Sousa, Gabriela
    Batel-Marques, Francisco
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (01) : 133 - 140
  • [22] Memory impairment associated with vareniclineA case series from the New Zealand Intensive Medicines Monitoring Programme
    Ming Tan
    Mira Harrison-Woolrych
    European Journal of Clinical Pharmacology, 2013, 69 (5) : 1195 - 1196
  • [23] THE NATURAL HISTORY, TREATMENT AND SURVEILLANCE OF GANGLIONEUROMAS IN CHILDREN AND ADOLESCENTS
    Alexander, Natasha
    Sullivan, Katie
    Irwin, Meredith
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S59 - S59
  • [24] Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK
    Thompson, A
    Nazir, S
    Sorour, W
    DRUG SAFETY, 2006, 29 (06) : 549 - 549
  • [25] Effects of the Committee on Safety of Medicines Advice on Antidepressant Prescribing to Children and Adolescents in the UK
    Anne Thompson
    Saeed Nazir
    Walid Sorour
    Drug Safety, 2006, 29 : 549 - 549
  • [26] Effects of the committee on safety of medicines advice on antidepressant prescribing to children and adolescents in the UK
    Murray, ML
    Thompson, M
    Santosh, PJ
    Wong, ICK
    DRUG SAFETY, 2005, 28 (12) : 1151 - 1157
  • [27] Effects of the Committee on Safety of Medicines Advice on Antidepressant Prescribing to Children and Adolescents in the UK
    Macey L. Murray
    Mary Thompson
    Paramala J. Santosh
    Ian C.K. Wong
    Drug Safety, 2005, 28 : 1151 - 1157
  • [28] TARDIVE-DYSKINESIA AND OTHER CLINICAL CONSEQUENCES OF NEUROLEPTIC TREATMENT IN CHILDREN AND ADOLESCENTS
    GUALTIERI, CT
    QUADE, D
    HICKS, RE
    MAYO, JP
    SCHROEDER, SR
    AMERICAN JOURNAL OF PSYCHIATRY, 1984, 141 (01): : 20 - 23
  • [29] Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena)
    Zhou, LF
    Harrison-Woolrych, M
    Coulter, DM
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2003, 12 (05) : 371 - 377
  • [30] Open letter to Annette King, Minister of Health, New Zealand - Intensive medicines monitoring programme is not due to be stopped
    Matheson, D
    BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7463): : 460 - 460
12345